BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17014703)

  • 1. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
    Grigoriadis A; Mackay A; Reis-Filho JS; Steele D; Iseli C; Stevenson BJ; Jongeneel CV; Valgeirsson H; Fenwick K; Iravani M; Leao M; Simpson AJ; Strausberg RL; Jat PS; Ashworth A; Neville AM; O'Hare MJ
    Breast Cancer Res; 2006; 8(5):R56. PubMed ID: 17014703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.
    Jones C; Mackay A; Grigoriadis A; Cossu A; Reis-Filho JS; Fulford L; Dexter T; Davies S; Bulmer K; Ford E; Parry S; Budroni M; Palmieri G; Neville AM; O'Hare MJ; Lakhani SR
    Cancer Res; 2004 May; 64(9):3037-45. PubMed ID: 15126339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
    Smalley MJ; Iravani M; Leao M; Grigoriadis A; Kendrick H; Dexter T; Fenwick K; Regan JL; Britt K; McDonald S; Lord CJ; Mackay A; Ashworth A
    Breast Cancer Res; 2007; 9(6):R85. PubMed ID: 18067675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate.
    Kendrick H; Regan JL; Magnay FA; Grigoriadis A; Mitsopoulos C; Zvelebil M; Smalley MJ
    BMC Genomics; 2008 Dec; 9():591. PubMed ID: 19063729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
    Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
    BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global transcriptome and sequenome analysis of formalin-fixed salivary epithelial-myoepithelial carcinoma specimens.
    Fonseca I; Bell A; Wani K; Bell D
    Genes Chromosomes Cancer; 2015 Apr; 54(4):249-59. PubMed ID: 25546727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed sense and antisense transcript pairs in breast epithelial tissues.
    Grigoriadis A; Oliver GR; Tanney A; Kendrick H; Smalley MJ; Jat P; Neville AM
    BMC Genomics; 2009 Jul; 10():324. PubMed ID: 19615061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
    Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
    Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
    Nuzzo PV; Rubagotti A; Zinoli L; Salvi S; Boccardo S; Boccardo F
    BMC Cancer; 2016 Feb; 16():95. PubMed ID: 26872609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
    Abd El-Rehim DM; Ball G; Pinder SE; Rakha E; Paish C; Robertson JF; Macmillan D; Blamey RW; Ellis IO
    Int J Cancer; 2005 Sep; 116(3):340-50. PubMed ID: 15818618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter.
    Chen YJ; Huang CS; Phan NN; Lu TP; Liu CY; Huang CJ; Chiu JH; Tseng LM; Huang CC
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34387660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
    Alexopoulou AN; Leao M; Caballero OL; Da Silva L; Reid L; Lakhani SR; Simpson AJ; Marshall JF; Neville AM; Jat PS
    Breast Cancer Res; 2010; 12(4):R51. PubMed ID: 20642837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.
    Keller PJ; Lin AF; Arendt LM; Klebba I; Jones AD; Rudnick JA; DiMeo TA; Gilmore H; Jefferson DM; Graham RA; Naber SP; Schnitt S; Kuperwasser C
    Breast Cancer Res; 2010; 12(5):R87. PubMed ID: 20964822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression.
    Oudes AJ; Roach JC; Walashek LS; Eichner LJ; True LD; Vessella RL; Liu AY
    BMC Cancer; 2005 Jul; 5():86. PubMed ID: 16042785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.